
### [NCIT:C4123](http://purl.obolibrary.org/obo/NCIT_C4123)
**Label:** Adenocarcinoma In Situ

**Subclasses:** [NCIT:C4018](http://purl.obolibrary.org/obo/NCIT_C4018) (Lobular Breast Carcinoma In Situ), [NCIT:C8758](http://purl.obolibrary.org/obo/NCIT_C8758) (Stage 0 Lung Adenocarcinoma AJCC v6 and v7), [NCIT:C6877](http://purl.obolibrary.org/obo/NCIT_C6877) (Grade III Glandular Intraepithelial Neoplasia), [NCIT:C8894](http://purl.obolibrary.org/obo/NCIT_C8894) (Stage 0 Bladder Adenocarcinoma), [NCIT:C66933](http://purl.obolibrary.org/obo/NCIT_C66933) (Ductal Breast Carcinoma In Situ, Solid Type), [NCIT:C8376](http://purl.obolibrary.org/obo/NCIT_C8376) (Adenocarcinoma In Situ in Villous Adenoma), [NCIT:C7680](http://purl.obolibrary.org/obo/NCIT_C7680) (Adenocarcinoma In Situ in a Polyp), [NCIT:C4195](http://purl.obolibrary.org/obo/NCIT_C4195) (Ductal Breast Carcinoma In Situ and Lobular Carcinoma In Situ), [NCIT:C40105](http://purl.obolibrary.org/obo/NCIT_C40105) (Stage 0 Fallopian Tube Cancer), [NCIT:C126449](http://purl.obolibrary.org/obo/NCIT_C126449) (Serous Tubal Intraepithelial Carcinoma), [NCIT:C134914](http://purl.obolibrary.org/obo/NCIT_C134914) (Stage 0 Pancreatic Cancer AJCC v8), [NCIT:C136716](http://purl.obolibrary.org/obo/NCIT_C136716) (Non-Mucinous Lung Adenocarcinoma In Situ), [NCIT:C136717](http://purl.obolibrary.org/obo/NCIT_C136717) (Mucinous Lung Adenocarcinoma In Situ), [NCIT:C5729](http://purl.obolibrary.org/obo/NCIT_C5729) (Stage 0 Pancreatic Cancer AJCC v6 and v7), [NCIT:C8629](http://purl.obolibrary.org/obo/NCIT_C8629) (Stage 0 Esophageal Adenocarcinoma AJCC v7), [NCIT:C133894](http://purl.obolibrary.org/obo/NCIT_C133894) (Stage 0 Small Intestinal Adenocarcinoma AJCC v8), [NCIT:C4520](http://purl.obolibrary.org/obo/NCIT_C4520) (Cervical Adenocarcinoma In Situ), [NCIT:C7678](http://purl.obolibrary.org/obo/NCIT_C7678) (Adenocarcinoma In Situ in Adenomatous Polyp), [NCIT:C5137](http://purl.obolibrary.org/obo/NCIT_C5137) (Intraductal Non-Comedo Breast Adenocarcinoma), [NCIT:C5138](http://purl.obolibrary.org/obo/NCIT_C5138) (Intraductal Cribriform Breast Adenocarcinoma), [NCIT:C7679](http://purl.obolibrary.org/obo/NCIT_C7679) (Adenocarcinoma In Situ in Tubular Adenoma), [NCIT:C4144](http://purl.obolibrary.org/obo/NCIT_C4144) (Adenocarcinoma In Situ in Tubulovillous Adenoma), [NCIT:C136486](http://purl.obolibrary.org/obo/NCIT_C136486) (Lung Adenocarcinoma In Situ), [NCIT:C2924](http://purl.obolibrary.org/obo/NCIT_C2924) (Ductal Breast Carcinoma In Situ), [NCIT:C67493](http://purl.obolibrary.org/obo/NCIT_C67493) (Biliary Intraepithelial Neoplasia-3), [NCIT:C137839](http://purl.obolibrary.org/obo/NCIT_C137839) (Pleomorphic Lobular Breast Carcinoma In Situ), 

**Class expressions from DL-Learner:**

- Thing 53.40%
- [NCIT:C28079](http://purl.obolibrary.org/obo/NCIT_C28079) (Grade 3) 52.78%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 38.13%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40163](http://purl.obolibrary.org/obo/NCIT_C40163) (Uterine Corpus Cellular Leiomyoma))) 38.13%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40162](http://purl.obolibrary.org/obo/NCIT_C40162) (Uterine Corpus Leiomyoma, Mitotically Active Variant))) 38.13%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40161](http://purl.obolibrary.org/obo/NCIT_C40161) (JAZF1-SUZ12 Fusion Protein Expression))) 38.13%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40160](http://purl.obolibrary.org/obo/NCIT_C40160) (t(7;17)(p15;q21)))) 38.13%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40156](http://purl.obolibrary.org/obo/NCIT_C40156) (Endometrial Undifferentiated Carcinoma))) 38.13%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40155](http://purl.obolibrary.org/obo/NCIT_C40155) (Endometrial Small Cell Carcinoma))) 38.13%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40154](http://purl.obolibrary.org/obo/NCIT_C40154) (Endometrial Transitional Cell Carcinoma))) 38.13%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40153](http://purl.obolibrary.org/obo/NCIT_C40153) (Endometrial Mixed Adenocarcinoma))) 38.13%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40152](http://purl.obolibrary.org/obo/NCIT_C40152) (Serous Endometrial Intraepithelial Carcinoma))) 38.13%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40151](http://purl.obolibrary.org/obo/NCIT_C40151) (Grade 3 Endometrial Mucinous Adenocarcinoma))) 38.13%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40150](http://purl.obolibrary.org/obo/NCIT_C40150) (Grade 2 Endometrial Mucinous Adenocarcinoma))) 38.13%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40149](http://purl.obolibrary.org/obo/NCIT_C40149) (Grade 1 Endometrial Mucinous Adenocarcinoma))) 38.13%


